Citadel Advisors’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
113,495
-55,426
-33% -$526K ﹤0.01% 7938
2026
Q1
$1.45M Sell
168,921
-70,711
-30% -$634K ﹤0.01% 6797
2025
Q4
$2.12M Buy
+239,632
New +$2.77M ﹤0.01% 5799
2025
Q3
Sell
-46,277
Closed -$579K 14420
2025
Q2
$632K Sell
46,277
-41,029
-47% -$552K ﹤0.01% 8075
2025
Q1
$1.2M Sell
87,306
-62,694
-42% -$915K ﹤0.01% 6552
2024
Q4
$2.56M Sell
150,000
-856,858
-85% -$14.9M ﹤0.01% 5132
2024
Q3
$18.5M Buy
+1,006,858
New +$17.8M ﹤0.01% 2127

Other funds holding ARDT

Citadel Advisors's ARDT Position: Q2 2026 in Review

Citadel Advisors reduced its Ardent Health (ARDT) stake by 33% in Q2 2026, selling an estimated $526K and leaving 113,495 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #7938.

Citadel Advisors first reported a position in ARDT in Q3 2024 and has held it in 7 quarters since. The position peaked at $18.5M in Q3 2024. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • Citadel Advisors held 113,495 shares of Ardent Health worth $1.12M as of Q2 2026.
  • Citadel Advisors sold 55,426 Ardent Health shares in Q2 2026, an estimated $526K.
  • Ardent Health made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7938 holding.
  • Citadel Advisors first reported a position in Ardent Health in Q3 2024 and has held it in 7 quarters since.
  • Citadel Advisors's Ardent Health position peaked at $18.5M in Q3 2024.
  • 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.